جست‌وجوی استاد و پژوهشگر

Samantha Kingمشاهده پروفایل

استاد

• Cultural Studies
• Sociology
• Health Studies
• +۵ مورد دیگر

Samantha King is a Professor in the Department of Kinesiology and Health Studies at Queen's University. She holds a PhD from the University of Illinois at Urbana-Champaign. Her interdisciplinary research integrates feminist, queer, and critical race theories to examine the intersections of health, sport, and the body. She leads the King Research Group, based in KINE 206J & 301V offices. King's research interests span topics such as drug cultures, food politics, and the sociology of sport. Her influential work includes the book Pink Ribbons, Inc: Breast Cancer and the Politics of Philanthropy , adapted into an NFB documentary. She explores themes like pharmaceutical use in professional sports, the ecological dimensions of embodiment, and multispecies approaches to sport studies. Her recent publications analyze racial capitalism in NFL pain management, pandemic-era human-animal relations, and the sociological implications of whey protein consumption. She has co-edited volumes on food ethics and bodily embodiment, reflecting her commitment to interdisciplinary dialogue. Her work bridges cultural studies, sociology, and health studies, addressing contemporary issues in sport, medicine, and everyday life. King’s academic contributions include over 30 peer-reviewed articles and edited collections. She has received international attention for critiquing corporate philanthropy in health activism and challenging normative frameworks in sport studies. Her current projects explore multispecies methodologies and the political economies of meat production.

Sara Häggمشاهده پروفایل

مدرس ارشد

• Epidemiology
• Gerontology
• Medical Genetics and Genomics
• +۳ مورد دیگر

Sara Hägg is a Senior Lecturer at the Karolinska Institutet , affiliated with the Department of Medical Epidemiology and Biostatistics . She is also a Docent in molecular epidemiology. PhD in Computational Biology (Linköping University, 2009) MSc in Molecular Biology (Stockholm University, 2003) BSc in Computer Science (Stockholm University, 2003) Her research focuses on human biological aging , including measurement of aging markers (telomere length, epigenetic clocks, frailty index), causal pathway analysis, and identification of geroprotectors for age-related diseases. She utilizes longitudinal twin studies (SATSA, GENDER, HARMONY), UK Biobank, and Swedish cohorts with methods like Mendelian randomization and genome-wide analyses . Recent articles demonstrate trends in epidemiological aging research , with emphasis on cardiovascular aging , neurological disease interactions , metabolic profiling , and epigenetic clocks . Her work often involves multivariable modeling and cross-cohort validation . Leadership roles include Director of LifeGene Core Facility (2024-) and Founding Board Member of the Nordic Aging Society (2023-). She serves on expert groups for the Swedish Twin Registry and Strategic Research Area in Epidemiology and Biostatistics .

Angelica Lindén Hirschbergمشاهده پروفایل

استاد

• Reproductive Medicine
• Endocrinology
• Polycystic Ovary Syndrome (PCOS)
• +۵ مورد دیگر

Angelica Lindén Hirschberg is a Professor of Obstetrics and Gynecology (specializing in reproductive medicine) at Karolinska Institutet and a Senior Consultant in gynecological endocrinology at Karolinska University Hospital. She holds dual roles in academic leadership and clinical practice, focusing on disorders of reproductive function, endocrine-metabolic dysfunction, and hormonal conditions in women. Her affiliations include the Department of Women’s and Children’s Health, Reproductive Endocrinology and Metabolism Research Group, and the Division for Neonatology, Obstetrics, Gynaecology, and Reproductive Health. Education and Career: MD (Karolinska Institutet, 1984) PhD (Karolinska Institutet, 1989) Professor in Obstetrics and Gynecology (2007) Board member of international societies (ISGE, EMAS) Research Focus: Her translational research spans PCOS, obesity-related reproductive dysfunction, premature ovarian insufficiency, and disorders of sex development. Projects include hormonal impacts on athletic performance, immune therapy for ovarian dysfunction, and endometrial cell biology. Collaborations involve national/international networks and clinical trials (e.g., PROBES trial). Publications: Recent work emphasizes PCOS pathophysiology, menopausal health, and hormonal interventions in athletes. Key trends include single-cell profiling of endometrium, immunomodulatory therapies for POI, and non-hormonal treatments for vasomotor symptoms. Awards: King’s Seraphim Medal (2018) 2016 Grand Prize in Sport Science Appointed Royal Gynecologist (2009) Teaching and Mentorship: Coordinates courses on reproductive endocrinology, supervises PhD students (e.g., Esin Ylmaz), and chairs the PhD Study Director at her department. Authored over 25 book chapters on women’s health and sports medicine. Grants and Labs: Secured Swedish Research Council funding for POI trials. Her lab integrates experimental (Bioclinicum) and clinical (Women’s Health Research Unit) research.

Soeren Lienkampمشاهده پروفایل

استادیار

• Molecular Biology
• Genetics
• Developmental Biology
• +۵ مورد دیگر

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.

• Algorithmic Fairness
• Responsible AI
• Deep Learning
• +۷ مورد دیگر

Golnoosh Farnadi is an Associate Professor at the Department of Computer Science and Operational Research at the University of Montreal and an Assistant Professor at the School of Computer Science at McGill University. She holds a Canada-CIFAR Chair in Artificial Intelligence and serves as a Senior Academic Member at Mila - Quebec Institute for Artificial Intelligence. Her interdisciplinary work bridges computer science, operations research, and ethical AI considerations. Her educational background includes a Ph.D. in Computer Science from KU Leuven and Ghent University (2017), followed by postdoctoral positions at the University of Montreal/MILA (2018-2020) and the University of California, Santa Cruz (2017-2018). Her research focuses on algorithmic fairness, responsible AI, deep learning, and probabilistic models, with applications spanning healthcare, recommender systems, and public policy. Farnadi's recent publications demonstrate a strong emphasis on addressing fairness in machine learning systems, with particular attention to cultural diversity in recommender systems, fairness in healthcare optimization (particularly kidney exchange programs), and mitigating hallucinations in large language models. Her work consistently combines theoretical rigor with practical applications, often employing novel mathematical frameworks to tackle complex ethical challenges in AI. Among her notable recognitions are the Google Scholar Award (2021), Facebook Research Award (2021), Google Award for Inclusion Research (2023), and being named one of the 100 Brilliant Women in AI Ethics (2023). She was also recognized as a Rising Star in AI Ethics in 2021. Farnadi supervises numerous graduate students through her EQUAL Lab (EQuity & EQuality Using AI and Learning algorithms), which focuses on developing AI systems that promote fairness and equity. Her teaching includes courses on Responsible AI, Machine Learning, and Trustworthy Machine Learning at both McGill University and HEC Montreal.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

Joanne Wangمشاهده پروفایل

استاد

• Blood-brain and blood-csf barriers
• Pharmacokinetics-Pharmacodynamics
• Pharmacology
• +۵ مورد دیگر

Joanne Wang is Professor of Pharmaceutics at the University of Washington School of Pharmacy and an Affiliate Investigator at the Fred Hutchinson Cancer Research Center. She holds additional appointments in multiple research centers including the Obstetric-fetal Pharmacology Research Unit (OPRU), Plein Center for Aging Faculty, and Pharmaceutics Faculty. Her educational background includes: PhD in Pharmaceutical Chemistry, University of California, San Francisco (UCSF) MS in Biochemistry, University of Illinois at Chicago BS in Biochemistry, Peking University Dr. Wang's research focuses on solute carrier (SLC) and ATP-binding cassette (ABC) transporters that shuttle drugs, nutrients, neurotransmitters, and hormones across cell membranes. Her work encompasses elucidating mechanisms and clinical impact of transporters in nutrient and drug disposition and their potential as drug targets. Ongoing projects include identification and functional characterization of transporters in human placenta, mechanisms of drug secretion into breastmilk using PBPK modeling, and investigation of transporters in the disposition of meta-iodobenzylguanidine for cancer therapy. Analysis of her recent publications reveals a strong emphasis on transporter-mediated drug disposition in special populations, particularly during pregnancy and lactation, and at the blood-brain barrier. Her work spans from basic transporter characterization to clinical applications, with increasing focus on translational aspects including PBPK modeling and clinical implications of transporter polymorphisms. Dr. Wang is actively involved in mentoring, as evidenced by her lab accepting students. Her research has been supported by significant grants including a UC2 grant from NICHD for placental transporter research. Her multidisciplinary approach integrates in vitro models, in vitro-in vivo extrapolation, and PBPK modeling to address critical questions in drug disposition. She is affiliated with several research centers including the Obstetric-fetal Pharmacology Research Unit (OPRU), Plein Center for Aging, and the Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH), reflecting the breadth and impact of her work across multiple domains of pharmacology and therapeutics.

• Cardiovascular Physiology
• Exercise Physiology
• Vascular Function
• +۴ مورد دیگر

Joe Stock is an Assistant Professor in Kinesiology at East Carolina University's College of Health and Human Performance. He operates the Human Performance Lab, focusing on cardiovascular wellness in aging and at-risk populations. B.S. in Exercise Science, Slippery Rock University M.S. in Health, Physical Activity and Chronic Disease, University of Pittsburgh Ph.D. in Kinesiology and Applied Physiology, University of Delaware His research examines aortic hemodynamics, vascular function, and lifestyle interventions through echocardiography, blood vessel ultrasound, and non-invasive blood pressure analysis. He explores sex differences in neurocardiovascular responses and salt sensitivity mechanisms. Recent publications demonstrate expertise in chronic kidney disease adaptations, exercise-induced vascular changes, and central sodium sensing. Collaborations span cardiovascular physiology, nephrology, and autonomic neuroscience. National Heart, Lung, and Blood Institute grant (2021-2023) University of Delaware Dissertation Fellowship (2019) University of Delaware Summer Doctoral Fellowship (2018) Professional service includes American Heart Association membership, ACSM regional committee work, and development of clinical exercise programs for renal patients. His work integrates applied physiology with translational medicine.

Allan Davidمشاهده پروفایل

استاد

• Smart Materials
• Nanomedicine
• Cancer Research
• +۴ مورد دیگر

Allan David serves as the John W. Brown Professor of Chemical Engineering and Associate Dean for Research at Auburn University's Samuel Ginn College of Engineering. His leadership extends across academic administration and cutting-edge nanomedicine research, with a focus on translating laboratory discoveries into clinical applications. His educational foundation includes: Ph.D. in Chemical Engineering, University of Maryland B.S. in Chemical Engineering, University of Maryland Dr. David's research program pioneers nanomedicine applications through the development of smart materials for cancer diagnostics and therapy. His work spans nanoparticle-based MRI contrast agents , ocular drug delivery systems , and vaccine delivery platforms , with particular emphasis on optimizing physicochemical properties for targeted biological interactions. Current projects address critical healthcare challenges including safer contrast agents for patients with kidney impairment and precision cancer targeting mechanisms. Analysis of his 15 most recent publications reveals a cohesive research trajectory centered on magnetic nanoparticles and biomimetic delivery systems . The work demonstrates increasing translational focus, evolving from fundamental nanoparticle characterization (2020-2021) to clinically relevant applications like ocular delivery and cancer theranostics (2022-2024), culminating in commercialization efforts through NanoXort, LLC. Dr. David has secured significant research funding including an $184,773 grant from the Alabama Department of Economic and Community Affairs (ADECA) for developing cardiovascular MRI agents. He leads collaborative efforts that bridge chemical engineering with biomedical innovation, notably co-founding NanoXort, LLC to commercialize safer MRI contrast agents addressing gadolinium toxicity concerns for renal-impaired patients. His laboratory operates at the intersection of chemical engineering and medicine, focusing on nanoparticle-cell interactions and targeted delivery systems. The research group maintains strong industry partnerships through the NanoXort startup, which has secured $1 million NSF funding to advance MRI contrast agent technology toward clinical implementation.

Tim Coloniusمشاهده پروفایل

استاد

• Fluid Dynamics
• Cavitation and Bubble Dynamics
• Aerodynamic Sound
• +۵ مورد دیگر

Tim Colonius is the Frank and Ora Lee Marble Professor of Mechanical Engineering and Medical Engineering and holds the Cecil and Sally Drinkward Leadership Chair at the California Institute of Technology. He has been affiliated with Caltech since 1994 and currently serves as Executive Officer for Mechanical and Civil Engineering . Colonius earned his B.S. from the University of Michigan (Ann Arbor), and both his M.S. and Ph.D. from Stanford University. Research Interests: His work focuses on fluid dynamics (global instabilities, cavitation, aerodynamic sound), flow control (closed-loop control, reduced-order modeling), and biomedical applications (shock waves, lithotripsy, ultrasound). He also develops advanced numerical methods for interface capturing, immersed-boundary techniques, and high-order accuracy. Scientific Contributions: Recent publications highlight his research in multiphase flows, vortex ring collisions, turbulent jet analysis, GPU-accelerated simulations, and biomedical applications. His group uses computational and data-driven approaches to study turbulence, instabilities, and flow optimization. Scientific Awards: AIAA Aeroacoustics Award Fellow of the Acoustical Society of America Fellow of the American Physical Society (APS) NSF and DoD research grants

• Medical Physiology
• Oxidative Stress and Inflammation
• Medical Education Research
• +۲ مورد دیگر

Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .

Marshall J. Glesbyمشاهده پروفایل

استاد

• HIV Pathogenesis
• Aging in HIV Patients
• Co-infections
• +۵ مورد دیگر

Marshall J. Glesby is a Professor at Weill Cornell Medical College, affiliated with both the Department of Medicine and Population Health Sciences. His career spans over three decades, focusing on HIV pathogenesis, aging-related complications, and co-infections. He holds a Ph.D. from Johns Hopkins University School of Hygiene and Public Health (1997), an M.D. from Johns Hopkins University School of Medicine (1989), and a B.Sc. from McGill University (1985). Research Interests: His work integrates HIV, immunology, and public health, emphasizing co-infections, metabolic disorders, and cardiovascular complications. Recent studies explore geriatric syndromes, epigenetic aging, and biomarkers like extracellular vesicles in Long COVID and Alzheimer's disease. He leads clinical trials on Mpox severity scoring and HIV-kidney transplantation. Grants and Collaborations: Dr. Glesby is a key investigator for NIH-funded projects, including PORTENT (NIAID) and STRIVE (NIAID). He contributes to global HIV research networks like INSIGHT and ACTG, with subawards from the National Institute of Child Health & Human Development and NHLBI. External Relationships: He serves as a consultant for UpToDate, Inc., and collaborates with organizations such as the Northeast/Caribbean AIDS Education and Training Centers.

• Virology
• Molecular Pathology
• Host-Pathogen Interactions
• +۵ مورد دیگر

Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.

Dario Alessiمشاهده پروفایل

استاد

• Protein Phosphorylation
• Ubiquitylation Pathways
• Parkinson's Disease
• +۳ مورد دیگر

Professor Dario Alessi is a leading academic at the University of Dundee's School of Life Sciences, serving as the Director of the MRC Protein Phosphorylation Unit (MRC PPU) and Professor of Signal Transduction. He earned his BSc (1988) and PhD (1991) from the University of Birmingham. His research focuses on protein phosphorylation and ubiquitylation pathways, particularly the LRRK2 kinase pathway linked to Parkinson's disease. He has made groundbreaking contributions to understanding LRRK2's role in neurodegeneration, including its interaction with Rab proteins and scaffolding molecules like RILPL1. School of Life Sciences, University of Dundee MRC PPU Director since 2012 Signal Transduction Therapy Unit Director His work combines molecular biology, biochemistry, and collaborative industry partnerships to advance therapeutic strategies for Parkinson's disease. Key research areas include LRRK2 activation mechanisms, Rab protein phosphorylation, and lysosomal dysfunction. Alessi has trained over 30 graduate students and 40 postdocs, many now in academic and industry leadership roles. Notable awards include the EMBO Gold Medal (2005), the Robert A. Pritzker Prize for Leadership in Parkinson’s Research (2023), and an OBE (2023) for contributions to medical science. His lab promotes open science, sharing reagents and protocols globally through platforms like MRC Pure Agents and LRRK2.bio. Current projects include investigating novel mitochondrial and organelle biology in Parkinson’s, developing biomarkers, and advancing LRRK2 inhibitors through clinical trials. Collaborations span the Michael J. Fox Foundation, Aligning Science Across Parkinson’s, and the UK Dementia Research Initiative.

Karen Bandeen-Rocheمشاهده پروفایل

استاد

• Biostatistics
• Gerontology
• Aging
• +۱۴ مورد دیگر

Karen Bandeen-Roche is a Professor and the Hurley-Dorrier Professor and Chair of the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health, with joint affiliations in the School of Medicine and the School of Nursing. She is a leading expert in biostatistical methodology, particularly in latent variable models, longitudinal analysis, and multivariate survival methods applied to aging and gerontology. Her research focuses on developing statistical models for unobservable processes such as frailty, resilience, and functional status in older adults. She has made significant contributions to the measurement of aging-related constructs and has extensive collaborative work in ophthalmology and neurology. Her methodological work includes mixture models, measurement error correction, and latent class modeling. The recent publications highlight a strong trend in gerontological biostatistics, with a focus on frailty, dementia risk, resilience, and multisystem physiological responses in aging. Her work integrates complex data from observational cohorts and clinical studies, often employing innovative latent variable frameworks to address measurement challenges in health outcomes. Scientific Awards and Honors: Marvin Zelen Leadership Award in Statistical Science (2016) Fellow of the American Statistical Association (2001) Brookdale National Fellow (1997) Golden Apple Award for Excellence in Teaching (2010) Garland Clay Award (1999) Chair, NIH BMRD Study Section (2006–2008) President, Eastern North American Region, International Biometric Society (2011–2013) Executive Board, International Biometric Society (2015–2022) Board of Directors, National Institute of Statistical Sciences (2020–2023) Karen Bandeen-Roche has been deeply involved in advising and training the next generation of researchers. She co-directs a training program in Biostatistics and Epidemiology of Aging and has received multiple teaching and mentoring awards. She has served on numerous academic committees, including appointments and promotions, faculty senate, and ethics committees at Johns Hopkins. Her grants and collaborative research span aging, dementia, ophthalmology, and cardiovascular health, often supported by NIH and other federal agencies. She leads the Center on Aging and Health and is actively involved in interdisciplinary research initiatives that bridge biostatistics, medicine, and public health. Her lab and research team focus on developing and applying advanced statistical methods to understand the biological and social determinants of healthy aging.